GBA Presents: THE GREEN MARKET

TrailerParkTed said:
Biotech Master Stoney, CTIC? Its $3.05.

12,200 $3 March 22 Calls.
More...


Well it's post event... So I think you can count on a secondary announcement

CTI BioPharma price target raised to $12 from $7.20 at Brookline 10:16 CTIC Brookline analyst Leah Rush Cann raised the firm's price target on CTI BioPharma to $12 from $7.20 and keeps a Buy rating on the shares after the company announced the FDA approved Vonjo for the treatment of certain adults with intermediate or high-risk primary or secondary myelofibrosis. Rush Cann said the timing was as expected and the prescribing label, with no black box warning, is better than anticipated and based on the label she has adjusted her outlook to include more patients from the second-line setting.

Sounds very promising maybe time it with sell off if they raise $'s... Check their cash position.
Seems to me they have been around a while but I may be confusing Co's.
 
BEST IDEA->
Aerojet Rocketdyne Holdings, Inc. (AJRD)
39.09+0.34 (+0.88%)
As of 12:53PM EST.

BUT I worry about a peace selloff if a deal is struck over the weekend.-
 
stonedinvestor said:
MAKING A BOLD CALL HERE ON A FALLING KNIFE....

I'VE BEEN ITCHING TO BUY DOCCUSIGN SINCE I USED THE PRODUCT SIGNING SOME BANK FORMS.

IT HAS BEEN IN A SKI SLOP PATTERN A WATERFALL DECLINE...

AND NOW IT IS A BUY. Technical Picture Be Dammed! $115.....

DocuSign's massive opportunity
DocuSign is down 60% from its highs following investors' overreaction to its lower billings in Q3 of 2021. Despite that, the company is still healthy and growing. Its main product enables its 1.1 million global business customers to sign and collect signatures electronically, making a previously pen-and-paper process faster and easier. With just $1.5 billion of the $50 billion digital signature and agreement market in its grasp, DocuSign enjoys an enormous, still-growing market opportunity.

As that market expands, so does the company. From Q3 2020 to Q3 2021, its subscription revenue rose 50%. Overall revenue grew 35% in 2019 and 39% in 2020, and management expects 49% growth for 2021.

International revenue currently makes up only 23% of its total revenue, but it's growing very quickly – 68% year over year in the latest quarter. To keep enjoying that growth, DocuSign needs to keep an eye on regulatory risk abroad; some of the countries where it's currently growing fastest are debating whether electronic signatures are too prone to fraud.

DocuSign is trying to lock in its place in the market through its analytics tools, which its primary competitor, Adobe (NASDAQ:ADBE), lacks. Agreements between two parties often require extensive and sometimes expensive reviews. DocuSign Analyzer uses A.I. to determine risk and summarize the main points of the agreement. That exclusive feature's helping DocuSign land and keep customers: Existing clients spent 21% more year over year in Q3 2021, up from 17% in Q3 2020, suggesting that DocuSign's staying healthy despite rising competition.

Even so, the company isn't immune to the pandemic's effects. As businesses rushed to go digital, they pulled demand for DocuSign's services forward; the company grew faster than expected last year but slower than expected this year around, leading to the slower growth and smaller billings in Q3 that dismayed investors. But while the stock has spiraled downward, the company's still firing on all cylinders. As DocuSign gets bigger, growth will naturally slow – but it's clearly not coming to a halt.
More...




VAN! I'm all twisted up--- SELLING DOCU I know you followed me in... I do think this is $150+Co. I really do but like I said before just scared about markets reaction to earn (even good) which I think is still on the come.... I know it's only $5 I apologize.

DocuSign, Inc. (DOCU)- Where I can- flat or slightly up I'm skimming cash<------
NasdaqGS - NasdaqGS Real Time Price.
120.67+2.24 (+1.89%)
As of 12:57PM EST.
 
stonedinvestor said:
Out with a big gain it was three day event. :rolleyes: Toptick

(Van if you haven't noticed I have pulled all my longs before earnings and gotten back in if I want to it's just not worth the risk/reward.)
More...
You sure you got the right stock lol? You top ticked it alright. 3 days later it was down huge. Whaaatever. :rolleyes:

upload_2022-3-1_13-1-29.jpeg
 
vanzandt said:
You sure you got the right stock lol? You top ticked it alright. 3 days later it was down huge. Whaaatever. :rolleyes:

View attachment 279346
More...



Maybe I am... I had an average cost of $88 I don't know why that post has such a high price - I probably had bought in the days just before, sometimes I like to try and drum up the Robin Hood crew. I think I held a week or so I remember making money. I certainly didn't lose any.
 
stonedinvestor said:
Maybe I am... I had an average cost of $88 I don't know why that post has such a high price - I probably had bought in the days just before, sometimes I like to try and drum up the Robin Hood crew. I think I held a week or so I remember making money. I certainly didn't lose any.
More...
Yulia had me send you a PM. That's the little box above next to alerts. :rolleyes:
Better look.
 
Van I know you said you were doing work on earnings report do we dare? After the close today.


Dutch Bros Inc. to Host Fourth Quarter and Fiscal Year 2021 Conference Call and Webcast on March 1, 2022 :wtf:


GRANTS PASS, Ore., February 15, 2022--(BUSINESS WIRE)--Dutch Bros Inc. ("Dutch Bros") (NYSE: BROS), one of the fastest-growing brands in the foodservice and restaurant industry in the United States by location count, today announced that Joth Ricci, President and Chief Executive Officer, and Charley Jemley, Chief Financial Officer, will host a conference call and webcast to review financial results for the fourth quarter and fiscal year ended December 31, 2021 on Tuesday, March 1, 2022 at 5:00 PM Eastern Time (ET).
 
You must log in or register to reply here.
Back
Top